Cure.
New York, NY
Wilson Sonsini is proud to sponsor NewYorkBIO's 2025 Innovation Summit. This full-day event features panels and fireside discussions focused on some of the most important topics of our industry.
On September 30th from 3:15 - 4:00 PM ET Seth Flaum will be moderating a panel discussion “Partnering for Scale: How Early-Stage Companies Can Win with Pharma,” with Daniyal Hussain, Executive Director of Technology Business Development at GSK and Jeff Raphael, Managing Partner at OmniScope Partners.
Madelaine Holden
mholden@wsgr.com
Seth Flaum is a partner in the New York office of Wilson Sonsini Goodrich & Rosati, where he is a member of the technology transactions practice. With more than 25 years of broad transactional experience, he represents life sciences companies in a wide range of strategic transactions and corporate matters.